close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Immunome, Inc.

< Previous 1 2 3 4 Next >
News headline image
Immunome to Present at 44th Annual J.P. Morgan Healthcare Conference
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Announces Pricing of Public Offering of Common Stock
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Announces Proposed Public Offering of Common Stock
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Announces Positive Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome to Announce Topline Results from Phase 3 RINGSIDE Trial of Varegacestat in Patients with Desmoid Tumors
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome to Present at Upcoming Investor Conferences
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Second Quarter 2025 Financial Results and Provides Business Update
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome to Present at Upcoming Investor Conferences
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports First Quarter 2025 Financial Results and Provides Business Update
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome to Present at the 24th Annual Needham Virtual Healthcare Conference
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Full Year 2024 Financial Results and Provides Business Update
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Doses First Patient in Phase 1 Trial of IM-1021, a ROR1-Targeted ADC
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome to Present at Upcoming March Conferences
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
Immunome Announces Pricing of Upsized Public Offering of Common Stock
From Immunome, Inc.
Via Business Wire
Tickers IMNM
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.